Dawn is a Managing Director in Deloitte’s Life Sciences practice, and a leader in Deloitte’s Clinical Transformation practice. She has more than 30 years of industry experience in Global Pharma and CROs across Clinical Development & Operations with an emphasis on enabling her life science clients to innovate and transformation the way they conduct clinical trials. She has a special focus on Clinical Transformation, Decentralized Trials, & enabling better recruitment, retention and diversity in Clinical Trials. Dawn’s clients span BioPharma, Medtech, CRO and Clinical Site Networks & prior to joining Deloitte, Dawn held executive positions at Global CROs, Site Networks, BioPharma, & Technology Companies.